The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 21, 2024

Filed:

May. 23, 2019
Applicant:

Brigham Young University, Provo, UT (US);

Inventors:

Laura Bridgewater, North Provo, UT (US);

Gongze Zhao, Highland, UT (US);

Assignee:

Optium, LLC, Provo, UT (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 35/76 (2015.01); A61K 35/745 (2015.01); A61K 35/747 (2015.01); A61K 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/76 (2013.01); A61K 35/745 (2013.01); A61K 35/747 (2013.01); A61K 2035/115 (2013.01);
Abstract

Compositions for affecting the intestinal microbiome of a mammalian subject can include a pharmaceutically-acceptable carrier and greater than or equal to 1×10PFU/mL or PFU/mg of bacteriophage having a tropism that includes an obesogenic and/or inflammatory bacterium associated with an intestinal microbiome of a mammal. Processes for preparing the disclosed compositions can include isolating the bacteriophage from an environmental source, characterizing the bacteriophage, and combining the bacteriophage with the pharmaceutically acceptable carrier at greater than or equal to 1×10PFU/mL or PFU/mg. Methods can include administering the disclosed compositions to a mammalian subject with or without co-administration of the disclosed probiotics. Administering the disclosed compositions can reduce a concentration of obesogenic and/or inflammatory bacteria in the intestinal microbiome of the mammalian subject, promote or induce weight loss, reduce inflammation, support metabolic health, and/or support a healthy balance/diversity within the intestinal microbiome of the mammalian subject.


Find Patent Forward Citations

Loading…